The prognosis and main prognostic indicators of Guillain-Barré syndrome: A multicentre prospective study of 297 patients

Brain

Volumn 119, Issue 6, 1996, Pages 2053-2061

  Beghi, Ettore ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Acute polyneuritis; Guillain barr ; Prognosis; Prognostic factor; Syndrome

Indexed keywords

ADOLESCENT; ADULT; AGE; ARTICLE; DISABILITY; DISEASE DURATION; ELECTROPHYSIOLOGY; FEMALE; FOLLOW UP; GASTROENTERITIS; GENDER; GUILLAIN BARRE SYNDROME; HUMAN; LATENT PERIOD; MAJOR CLINICAL STUDY; MALE; NEUROPATHY; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; SYMPTOM;

ADOLESCENT; ADULT; FEMALE; GASTROENTERITIS; HUMANS; INFLUENZA, HUMAN; MALE; MIDDLE AGED; POLYRADICULONEUROPATHY; PROGNOSIS; PROSPECTIVE STUDIES; RESPIRATORY TRACT INFECTIONS;

EID: 0030453518     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/119.6.2053     Document Type: Article

References (45)

1. Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). [Review]. Neurology 1991; 41: 617-18.
2. Alter M. The epidemiology of Guillain-Barré syndrome. Ann Neurol 1990; 27 Suppl: S7-S12.
3. Andersson T, Sidén A. A clinical study of the Guillain-Barré syndrome. Acta Neurol Scand 1982; 66: 316-27.
4. Beghi E, Kurland LT, Mulder DW, Wiederholt WC. Guillain-Barré syndrome. Clinicoepidemiologic features and effect of influenza vaccine. Arch Neurol 1985; 42: 1053-7.
5. Black MM, Lasek RJ. Slowing of the rate of axonal regeneration during growth and maturation. Exp Neurol 1979; 63: 108-19.
6. Bradshaw DY, Jones HR Jr. Guillain-Barré syndrome in children: clinical course, electrodiagnosis, and prognosis. Muscle Nerve 1992; 15: 500-6.
7. Cox DR. Regression models and life-tables. JR Stat Soc Series B 1972; 34: 187-220.
8. Eiben RM, Gersony WM. Recognition, prognosis and treatment of the Guillain-Barré syndrome (acute idiopathic polyneuritis). Med Clin N Am 1963; 47: 1371-80.
9. Feasby TE, Gilbert JJ, Brown WF, Bolton CF, Hahn AF, Koopman WF, et al. An acute axonal form of Guillain-Barré polyneuropathy. Brain 1986; 109: 1115-26.
10. French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome. Efficiency of plasma exchange in Guillain-Barré syndrome: role of replacement fluids. Ann Neurol 1987; 22: 753-61.
11. French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome. Plasma exchange in Guillain-Barré syndrome: one-year follow-up. Ann Neurol 1992; 32: 94-7.
12. Griffin JW, Ho TW. The Guillain-Barré syndrome at 75: the Campylobacter connection. Ann Neurol 1993; 34: 125-7.
13. Griffin JW, Li CY, Ho TW, Xue P, Macko C, Gao CY, et al. Guillain-Barré syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases. [Review]. Brain 1995; 118: 577-95.
14. Guillain-Barré Syndrome Steroid Trial Group. Double-blind trial of intravenous methylprednisolone in Guillain-Barré syndrome. Lancet 1993; 341: 586-90.
15. Guillain-Barré Syndrome Study Group. Plasmapheresis and acute Guillain-Barrè syndrome. Neurology 1985; 35: 1096-104.
16. 2-T-cell line mediated experimental autoimmune neuritis by interleukin-2 receptor blockade. Ann NY Acad Sci 1988; 540: 563-5.
17. Ho TW, Mishu B, Li CY, Gao CY, Cornblath DR, Griffin JW, et al. Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 1995; 118: 597-605.
18. Hughes RAC, Newsom-Davis JM, Perkin GD, Pierce JM. Controlled trial of prednisolone in acute polyneuropathy. Lancet 1978; 2: 750-3.
19. Italian Guillain-Barré Study Group. Audit of care of acute inflammatory polyradiculoneuropathy in Italy. Pharmacoepidemiol Drug Saf 1995; 4: 137-46.
20. Jiang G-X, de Pedro-Cuesta J, Fredrikson S, Guillain-Barré syndrome in South-West Stockholm, 1973-1991, 1. Quality of registered hospital diagnoses and incidence. Acta Neurol Scand 1995; 91: 109-17.
21. Kaur U, Chopra JS, Prabhakar S, Radhakrishnan K, Rana S. Guillain-Barré syndrome. A clinical electrophysiological and biochemical study. Acta Neurol Scand 1986; 73: 394-402.
22. Kleyweg RP, van der Meché FGA, Loonen MCB, de Jonge J, Knip B. The natural history of the Guillain-Barré syndrome in 18 children and 50 adults. J Neurol Neurosurg Psychiatry 1989; 52: 853-6.
23. Koobatian TJ, Birkhead GS, Schramm MM, Vogt RL. The use of hospital discharge data for public health surveillance of Guillain-Barré syndrome. Ann Neurol 1991; 30: 618-21.
24. McKhann GM, Griffin JW, Cornblath DR, Mellits ED, Fisher RS, Quaskey SA. Plasmapheresis and Guillain-Barré syndrome: analysis of prognostic factors and the effect of plasmapheresis. Ann Neurol 1988; 23: 347-53.
25. McKhann GM, Cornblath DR, Griffin JW, Ho TW, Li CY, Jiang Z, et al. Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann Neurol 1993; 33: 333-42.
26. National Institutes of Neurological and Communicative Disorders and Stroke Committee. Criteria for diagnosis of Guillain-Barré syndrome. Ann Neurol 1978; 3: 565-6.
27. Palace JA, Hughes RAC. Guillain-Barré syndrome with severe persistent disability: relationship to hyperacute Guillain-Barré syndrome. Eur J Neurol 1994; 1: 21-7.
28. Pestronk A, Drachman DB, Griffin JW. Effects of aging on nerve sprouting and regeneration. Exp Neurol 1980; 70: 65-82.
29. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Br J Cancer 1977; 35: 1-39.
30. Pleasure DE, Lovelace RE, Duvoisin RC. The prognosis of acute polyradiculoneuritis. Neurology 1968; 18: 1143-8.
31. Raphael JC, Masson C, Morice V, Brunel D, Gajdos P, Barois A, et al. Le syndrome de Landry-Guillain-Barré. Etude des facteurs pronostiques dans 223 cas. Rev Neurol (Paris) 1986; 142: 613-24.
32. Ravn H. The Landry-Guillain-Barré syndrome. A survey and a clinical report of 127 cases. Acta Neurol Scand 1967; 43 Suppl 30.
33. Rees JH, Soudain SE, Gregson NA, Hughes RAC. Campylobacter jejuni infection and Guillain-Barré syndrome [see comments]. N Eng J Med 1995; 333: 1374-9.
34. Ropper AH, Wijdicks EFM, Truax BT, editors. Guillain-Barré syndrome. Philadelphia: F. A. Davis, 1991.
35. Samantray SK, Johnson SC, Mathai KV, Pulimood BM. Landry-Guillain-Barré-Strohl syndrome. A study of 302 cases. Med J Aust 1977; 2: 84-91.
36. Statistical Package for the Social Sciences 4.1/4.0 for VAX/VMS. [computer program]. Maynard (MN): Digital Equipment Corporation, 1995.
37. Thomas PK. The Guillain-Barré syndrome: no longer a simple concept [editorial]. J Neurol 1992; 239: 361-2.
38. van der Meché FGA, Schmitz PIM, Dutch Guillain-Barré Study Group. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome [see comments]. N Eng J Med 1992; 326: 1123-9.
39. van Doom PA, Brand A, Vermeulen M. Clinical significance of antibodies against peripheral nerve tissue in inflammatory polyneuropathy. Neurology 1987; 37: 1798-802.
40. Winer JB, Hughes RAC, Greenwood RJ, Perkin GD, Healy MJR. Prognosis in Guillain-Barré syndrome. Lancet 1985; 1: 1202-3.
41. Winer JB, Hughes RAC, Osmond C. A prospective study of acute idiopathic neuropathy. I. Clinical features and their prognostic value, J Neurol Neurosurg Psychiatry 1988; 51: 605-12.
42. Yuki N, Miyatake T. Axonal Guillain-Barré syndrome [letter]. Neurology 1993; 43: 1443.
43. Yuki N, Yoshino H, Sato S, Miyatake T. Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis [see comments]. Neurology 1990; 40: 1900-2. Comment in: Neurology 1991; 41: 1327-8, Comment in: Neurology 1991; 41: 1530-1.
44. Yuki N, Yoshino H, Sato S, Miyatake T. Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis [see comments]. Neurology 1990; 40: 1900-2. Comment in: Neurology 1991; 41: 1327-8, Comment in: Neurology 1991; 41: 1530-1.
45. Yuki N, Yoshino H, Sato S, Miyatake T. Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis [see comments]. Neurology 1990; 40: 1900-2. Comment in: Neurology 1991; 41: 1327-8, Comment in: Neurology 1991; 41: 1530-1.